Abstract: A carryback material collection system is provided for assessing carryback material received from a conveyor belt. The carryback material collection system includes a tray positionable below the conveyor belt for receiving carryback material from the conveyor belt. The carryback material collection system further includes at least one sensor for detecting carryback material received in the tray. The carryback material collection system further includes a processing unit communicatively coupled with the at least one sensor for conveying information indicative of the carryback material detected by the at least one sensor. The carryback material collection system further includes a tray actuator that is operatively coupled to the tray to move the tray between a collection orientation to receive carryback material from the conveyor belt and a discharge orientation to discharge the carryback material from the tray.

Abstract: A suture passer instrument is disclosed that contains two opposing needles positioned adjacent to each other on the end of a hollow handle. The needles are at least partially hollow and the hollow in the needles is of a sufficient size so that a suture can be passed through an entry point near the tip of the needles through the hollow of the needles to the hollow in the handle of the instrument. Two suture ports are located toward the sharp end of the needles such that when the needle pierces through tissue the suture can be grasped and its end pulled through the hollow central chamber of the device.

Abstract: A deer stand is pivotally mountable on a back rack of an ATV. When erected to an upright position the deer stand is stabilized by the mass of the ATV, preventing collapse of the stand due to wind or other such forces. When being transported to the location, the stand is pivoted onto its side, with the front portion being securable to a front rack of the ATV.

Abstract: A composition for use in the treatment of wounds to inhibit scar tissue formation during healing is disclosed, comprising an effective activity-inhibiting amount of a growth factor neutralizing agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptable carrier. The method of preparation of the composition and method of administering the composition to a host suffering from tissue wounding is also disclosed.